Bazelet-Tech

Bazelet-Tech is the research and development division of the Bazelet Group, the largest medical cannabis company in Israel. The company specializes in the standardization and clinical optimization of cannabis-based medicines using its proprietary terpene enrichment technology. Bazelet-Tech develops indication-specific formulations tailored for conditions such as autism, epilepsy, and chronic pain, aiming to provide consistent therapeutic outcomes. Their operations include advanced manufacturing, genetic research, and the development of novel delivery methods to improve the safety and efficacy of cannabinoid therapies. The company is recognized for its focus on the "entourage effect" by precisely controlling the ratios of cannabinoids and terpenes in their products.